Evidence map›Paper›PMID 40486631›Full record

ReviewAnnals of medicine and surgery (2012)2025

Oxygen gradients in tumor tissues implications for breast cancer metastasis - a narrative review.

Emmanuel Ifeanyi Obeagu

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emmanuel Ifeanyi ObeaguDepartment of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxygen gradients within tumor tissues play a pivotal role in breast cancer metastasis, influencing critical biological processes that contribute to disease progression. Tumors often develop regions of hypoxia due to rapid growth and insufficient blood supply, which drives adaptation mechanisms that promote metastatic behavior. These low-oxygen areas trigger the activation of hypoxia-inducible factors (HIFs), which regulate genes involved in angiogenesis, epithelial-to-mesenchymal transition (EMT), and immune evasion. Such processes increase the capacity of cancer cells to migrate, invade distant organs, and survive under harsh conditions, contributing significantly to metastasis in breast cancer. The interaction between oxygen gradients and the tumor microenvironment (TME) is complex, with hypoxia inducing significant alterations in immune responses. Hypoxic regions of tumors often foster an immunosuppressive microenvironment by recruiting regulatory immune cells that inhibit the function of cytotoxic T cells and natural killer cells. This immune evasion not only allows the tumor to grow but also facilitates the spread of cancer cells to secondary sites. Furthermore, hypoxia-induced angiogenesis provides the necessary vasculature for metastatic cells to enter the bloodstream and seed distant organs, further enhancing the metastatic potential of breast cancer.

Indexed as

breast cancerhypoxia-inducible factorsmetastasisoxygen gradientstumor microenvironment

Identifiers

PMID40486631
PMCPMC12140756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.